Matches in Wikidata for { <http://www.wikidata.org/entity/Q90854942> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q90854942 description "article scientifique publié en 2019" @default.
- Q90854942 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q90854942 description "scientific article published on 18 October 2019" @default.
- Q90854942 description "wetenschappelijk artikel" @default.
- Q90854942 description "наукова стаття, опублікована 18 жовтня 2019" @default.
- Q90854942 name "The Role of TPMT, ITPA, and NUDT15 Variants during Mercaptopurine Treatment of Swedish Pediatric Patients with Acute Lymphoblastic Leukemia" @default.
- Q90854942 name "The Role of TPMT, ITPA, and NUDT15 Variants during Mercaptopurine Treatment of Swedish Pediatric Patients with Acute Lymphoblastic Leukemia" @default.
- Q90854942 type Item @default.
- Q90854942 label "The Role of TPMT, ITPA, and NUDT15 Variants during Mercaptopurine Treatment of Swedish Pediatric Patients with Acute Lymphoblastic Leukemia" @default.
- Q90854942 label "The Role of TPMT, ITPA, and NUDT15 Variants during Mercaptopurine Treatment of Swedish Pediatric Patients with Acute Lymphoblastic Leukemia" @default.
- Q90854942 prefLabel "The Role of TPMT, ITPA, and NUDT15 Variants during Mercaptopurine Treatment of Swedish Pediatric Patients with Acute Lymphoblastic Leukemia" @default.
- Q90854942 prefLabel "The Role of TPMT, ITPA, and NUDT15 Variants during Mercaptopurine Treatment of Swedish Pediatric Patients with Acute Lymphoblastic Leukemia" @default.
- Q90854942 P1433 Q90854942-D79938F8-CA4A-4AA8-8679-C3F6E467CB21 @default.
- Q90854942 P1476 Q90854942-BCA94C35-3C6C-4179-869A-BE8A4215154F @default.
- Q90854942 P2093 Q90854942-29C76081-E78B-42D9-A238-6FF0AE40499F @default.
- Q90854942 P2093 Q90854942-7991A43D-FDAC-44BE-A07E-329906E9D4EC @default.
- Q90854942 P2093 Q90854942-8433BBCE-340E-471C-A4B7-855743F03C5E @default.
- Q90854942 P2093 Q90854942-D303C9D7-681D-4B14-B51B-83AA2949B97B @default.
- Q90854942 P2093 Q90854942-D4CDA416-4627-4492-A6E5-15EC94D21E8C @default.
- Q90854942 P2093 Q90854942-FDD1AF27-9ADD-4571-B502-DC67AC8C6E1D @default.
- Q90854942 P31 Q90854942-6CC218E2-67A1-4E63-9862-4A968A5F5EB1 @default.
- Q90854942 P356 Q90854942-DF8C4EF3-9C4A-46EA-AB39-6F059E8F7182 @default.
- Q90854942 P50 Q90854942-6E6A98DB-9921-46A8-B1CF-03847D0DA2E4 @default.
- Q90854942 P577 Q90854942-E23497D5-4614-4263-B24D-B87FCA72B56A @default.
- Q90854942 P698 Q90854942-993F1BD8-9CC3-4952-80B9-8A3F271DB1D9 @default.
- Q90854942 P921 Q90854942-76EE4D85-882E-4761-B514-725A269110EB @default.
- Q90854942 P921 Q90854942-88F8C8CB-59D9-404E-8CFE-235069E8B386 @default.
- Q90854942 P356 J.JPEDS.2019.09.024 @default.
- Q90854942 P698 31635813 @default.
- Q90854942 P1433 Q7743611 @default.
- Q90854942 P1476 "The Role of TPMT, ITPA, and NUDT15 Variants during Mercaptopurine Treatment of Swedish Pediatric Patients with Acute Lymphoblastic Leukemia" @default.
- Q90854942 P2093 "Anna Nilsson" @default.
- Q90854942 P2093 "Anna Zimdahl Kahlin" @default.
- Q90854942 P2093 "Ida Hed Myrberg" @default.
- Q90854942 P2093 "Kristina Broliden" @default.
- Q90854942 P2093 "Malin Lindqvist Appell" @default.
- Q90854942 P2093 "Martina Wahlund" @default.
- Q90854942 P31 Q13442814 @default.
- Q90854942 P356 "10.1016/J.JPEDS.2019.09.024" @default.
- Q90854942 P50 Q90854939 @default.
- Q90854942 P577 "2019-10-18T00:00:00Z" @default.
- Q90854942 P698 "31635813" @default.
- Q90854942 P921 Q18553852 @default.
- Q90854942 P921 Q418529 @default.